Tina Morrison, PhD, Deputy Director, Division of Applied Mechanics and Chair of FDA’s Modeling and Simulation Working Group recently presented initiatives underway at the agency to advance the use of Modeling and Simulation.
FDA routinely advises industry on using modeling and simulation to, for example:
- Predict clinical outcomes
- Inform clinical trial designs
- Support evidence of effectiveness
- Identify the most relevant patients to study
- Predict product safety
Axendia would appreciate your input on a survey that focuses on the current use and perceived value of Modeling and Simulation in Life-Sciences.
The survey should take no longer than 10 minutes to complete and all individual responses will be kept strictly confidential. You are also welcome to register to receive a copy of the survey outcome.
The survey should take no longer than 10 minutes to complete and all individual responses will be kept strictly confidential. You are also welcome to register to receive a copy of the survey outcome.